Bansi Lal

Summary

Affiliation: Nicholas Piramal India Limited
Country: India

Publications

  1. ncbi Semisynthetic modifications of hemiaminal function at ornithine unit of mulundocandin, towards chemical stability and antifungal activity
    Bansi Lal
    Department of Medicinal Chemistry, Quest Institute of LifeSciences, Nicholas Piramal India Limited, Mulund w Mumbai 4000 80, India
    Bioorg Med Chem 11:5189-98. 2003
  2. ncbi Approaches towards the stabilization of hemiaminal function at ornithine unit of mulundocandin
    Bansi Lal
    Quest Institute of LifeScience, Nicholas Piramal India Limited, and Hoechst Research Center, Mulund, Mumbai 400080, Maharashtra, India
    Bioorg Med Chem Lett 14:1123-8. 2004
  3. ncbi Mannich reaction: an approach for the synthesis of water soluble mulundocandin analogues
    Bansi Lal
    Quest Institute of LifeSciences, Nicholas Piramal India Limited, Mulund W, Mumbai 4000 80, India
    Bioorg Med Chem 12:1751-68. 2004
  4. ncbi In vitro antitumor properties of a novel cyclin-dependent kinase inhibitor, P276-00
    Kalpana S Joshi
    Department of Pharmacology, Nicholas Piramal Research Center, Nicholas Piramal India Limited, 1 Nirlon Complex, Goregaon E, Mumbai 400 063, India
    Mol Cancer Ther 6:918-25. 2007

Collaborators

  • Maggie J Rathos
  • Kalpana S Joshi
  • Shrikant Kamble
  • Rajendra D Joshi
  • Meenakshi Sivakumar
  • Somesh Sharma
  • Malcolm Mascarenhas

Detail Information

Publications4

  1. ncbi Semisynthetic modifications of hemiaminal function at ornithine unit of mulundocandin, towards chemical stability and antifungal activity
    Bansi Lal
    Department of Medicinal Chemistry, Quest Institute of LifeSciences, Nicholas Piramal India Limited, Mulund w Mumbai 4000 80, India
    Bioorg Med Chem 11:5189-98. 2003
    ..Compound 9 has shown improved antifungal activity in comparison to mulundocandin by oral application in Swiss mice...
  2. ncbi Approaches towards the stabilization of hemiaminal function at ornithine unit of mulundocandin
    Bansi Lal
    Quest Institute of LifeScience, Nicholas Piramal India Limited, and Hoechst Research Center, Mulund, Mumbai 400080, Maharashtra, India
    Bioorg Med Chem Lett 14:1123-8. 2004
    ..Synthesized mulundocandin analogues were evaluated for their chemical stability and antifungal activity against C. albicans and A. fumigatus...
  3. ncbi Mannich reaction: an approach for the synthesis of water soluble mulundocandin analogues
    Bansi Lal
    Quest Institute of LifeSciences, Nicholas Piramal India Limited, Mulund W, Mumbai 4000 80, India
    Bioorg Med Chem 12:1751-68. 2004
    ..Compound 20, showed significant improvement in activity over mulundocandin (1) and activity compares well with that of fluconazole...
  4. ncbi In vitro antitumor properties of a novel cyclin-dependent kinase inhibitor, P276-00
    Kalpana S Joshi
    Department of Pharmacology, Nicholas Piramal Research Center, Nicholas Piramal India Limited, 1 Nirlon Complex, Goregaon E, Mumbai 400 063, India
    Mol Cancer Ther 6:918-25. 2007
    ..These data suggest that P276-00 has the potential to be developed as an anti-Cdk chemotherapeutic agent...